ReviewVaccines2026
Bridging the Gaps in Dengue Control in Latin America: Multisectoral Strategies from an Expert Panel.
Review in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the rubble: Dengue, Chikungunya, and Vector-Borne Disease risks after 2026 Venezuela's earthquake doublet.Le infezioni in medicina · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
In March 2025, the Americas Health Foundation (AHF) convened a regional meeting, in Bogotá, Colombia, of the Latin America Dengue Task Force, a multidisciplinary regional group of arbovirus specialists, to address the growing challenges posed by dengue in the region. The primary objective of the meeting was to analyze the regional dengue landscape, identify gaps and barriers that hinder a comprehensive approach, and develop a strategic blueprint for advancing control and prevention in Latin America. The Task Force conducted a thorough review of dengue-related issues, drawing on participants' professional expertise in vaccination, prevention, diagnosis, treatment, vector control, environmental determinants, and regulatory and policy frameworks. Key barriers identified include underreporting, widespread insecticide resistance, structural weaknesses in the health system, fragmented surveillance, financial and political constraints, and socioeconomic drivers. Based on these findings, actionable recommendations were developed to optimize regional dengue surveillance, strengthen prevention and diagnosis strategies, and improve coordination among stakeholders. This narrative review summarizes the epidemiological context, presents expert guidance to overcome existing limitations, and outlines strategies to advance integrated dengue control in Latin America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.